Specialty Pharmacy

Some patients may be unwilling to undergo traditional screening for cervical cancer.

Top news of the day from across the health care landscape.

GDC-0084 is a small molecule inhibitor of phosphatidylinositol 3-kinase with potential antineoplastic activity.

Specialty drugs are a large driver of health care spending.

Patients who exercise during chemotherapy may have lower levels of fatigue years after cancer treatments.

Cabozantinib (Cabometyx) treatment resulted in tumor shrinkage among patients with refractory thyroid cancer.

Top news of the week from Specialty Pharmacy Times.

Experimental therapy could improve lifespan for patients with amyotrophic lateral sclerosis.

Top news of the day from across the health care landscape.

Clarithromycin (Biaxin) may increase the risk of heart problems and death among patients with cardiovascular disease.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The new purchasing efforts may help increase biosimilar uptake and lower drug costs.

Teens in the criminal justice system have a higher risk of contracting HIV.

Health and Human Services Secretary Alex Azar could take action to help millions of Americans gain access to necessary drugs.

Many neuroendocrine cancers may be misdiagnosed without molecular pathway mapping.

There are significant unmet clinical needs among patients with amyotrophic lateral sclerosis.

Top news of the day from across the health care landscape.

Half of millennial-aged men and women said they have never been tested for HIV outside of blood donation.

New antiretroviral combination will be accessible to patients with HIV/AIDS in countries with limited resources.

Adolescent and young adult cancer survivors have a higher rate of heart disease, infertility, and cancer recurrence.

The Cx26 protein may be involved with promoting aggressive breast cancer.

An experimental antiviral drug shows promise fighting multiple infectious diseases.

Matt Gillin, Chief Executive Officer, Relay Network, speaks about takeaways specialty pharmacies can learn from other businesses in terms of customer communications, adoption, and behavior change.

Top news of the day from across the health care landscape.

Amazon's acquisition of Whole Foods could lead to pharmacies closing their doors.

Federal judge finds that sofosbuvir (Sovaldi) and ledipasvir/sofosbuvir (Harvoni) do not infringe on Merck patents.

If passed, a bill that addresses the prevention and treatment of chronic diseases may ensure better care for patients.

Deep transcranial stimulation could provide more relief from fatigue among multiple sclerosis patients compared with other treatments.